The protozoan parasite Trypanosoma cruzi, the aetiological agent of Chagas' disease, has two infective life cycle stages, trypomastigotes and amastigotes. While trypomastigotes actively enter mammalian cells, highly infective extracellular amastigotes (type I T. cruzi) rely on actin-mediated uptake, which is generally inefficient in non-professional phagocytes. We found that extracellular amastigotes (EAs) of T. cruzi G strain (type I), but not Y strain (type II), were taken up 100-fold more efficiently than inert particles. Mammalian cell lines showed levels of parasite uptake comparable to macrophages, and extensive actin recruitment and polymerization was observed at the site of entry. EA uptake was not dependent on parasite-secreted molecules and required the same molecular machinery utilized by professional phagocytes during large particle phagocytosis. Transcriptional silencing of synaptotagmin VII and CD63 significantly inhibited EA internalization, demonstrating that delivery of supplemental lysosomal membrane to form the phagosome is involved in parasite uptake. Importantly, time-lapse live imaging using fluorescent reporters revealed phagosome-associated modulation of phosphoinositide metabolism during EA uptake that closely resembles what occurs during phagocytosis by macrophages. Collectively, our results demonstrate that T. cruzi EAs are potent inducers of phagocytosis in non-professional phagocytes, a process that may facilitate parasite persistence in infected hosts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638054 | PMC |
http://dx.doi.org/10.1111/cmi.12090 | DOI Listing |
ACS Omega
January 2025
Laboratory of Natural Products and Mass Spectrometry (LAPNEM), Faculty of Pharmaceutical Sciences, Food, and Nutrition (FACFAN), Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Leishmaniases present a significant global health challenge with limited and often inadequate treatment options available. Traditional microscopic methods for detecting Leishmania amastigotes are time-consuming and error-prone, highlighting the need for automated approaches. This study aimed to implement and validate the YOLOv8 deep learning model for real-time detection, quantification, and categorization of Leishmania amastigotes to enhance drug screening assays.
View Article and Find Full Text PDFJ Chem Inf Model
January 2025
Institute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, Brazil.
Chagas disease, caused by the protozoan Trypanosoma cruzi, remains a significant global health burden, particularly in Latin America, where millions are at risk. This disease predominantly affects socioeconomically vulnerable populations, aggravating economic inequality, marginalization, and low political visibility. Despite extensive research, effective treatments are still lacking, partly due to the complex biology of the parasite and its infection mechanisms.
View Article and Find Full Text PDFACS Infect Dis
September 2024
Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Previously, we have demonstrated that deletion of a growth-regulating gene () in the parasite () attenuated the parasite's intracellular amastigote growth but not the growth of extracellular promastigotes. parasites were found to be safe and efficacious against homologous and heterologous species as a vaccine candidate in animal models. The reason for the differential growth of between the two stages of the parasite needed investigation.
View Article and Find Full Text PDFRSC Adv
July 2024
Department of Chemistry, Drug Design and Synthesis Lab., Jamia Millia Islamia Jamia Nagar New Delhi 110025 India +0091-11-26985507 +0091-9910200655.
Amongst the neglected tropical diseases, leishmaniasis alone causes 30 000 deaths annually due to the protozoan parasite genus . Existing therapies have serious drawbacks in safety, drug resistance, field-adapted application and cost. Therefore, new safer and shorter treatments are an urgent need of the time.
View Article and Find Full Text PDFBio Protoc
July 2024
Global Health, Biomedical Research, Novartis, Emeryville, CA, USA.
Diseases caused by trypanosomatid parasites remain a significant unmet medical need for millions of people globally. Trypanosomatid parasites such as and subspecies of cause Chagas disease and human African trypanosomiasis (HAT), respectively. Although efforts to find novel treatments have been successful for HAT, Chagas disease is still treated with decades-old therapies that suffer from long treatment durations and severe safety concerns.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!